Status: Recruiting
"SCRIBBLE" Spinal Cord Injury Blood Biomarker Longitudinal Evaluation
Prospective, single center study designed to assess blood biomarkers for classifying injury severity and predict neurologic recovery in traumatic spinal cord injured (SCI) patients. Study will also establish the accuracy of point to care devices for SCI blood biomarkers and support the biospecimen collection for the International Spinal Cord Injury Biobank (ISCIB).
Participants needed: 120
Trial details
Age: 19+Biological sex: AllType: ObservationalSponsor: University of British ColumbiaUpdated: Sep 23, 2026Locations: 1
Eligibility criteria
Male or Female ≥ 19 years of age [+11]
Penetrating spinal cord injury (e.g. gunshot, stab) [+6]